INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 136 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,362,951 | +3.9% | 19,900 | +5.0% | 0.00% | -20.0% |
Q1 2024 | $1,311,478 | -2.3% | 18,952 | +1.1% | 0.01% | 0.0% |
Q4 2023 | $1,342,016 | +87.2% | 18,738 | +36.1% | 0.01% | +66.7% |
Q3 2023 | $716,967 | +1.9% | 13,764 | +23.9% | 0.00% | 0.0% |
Q2 2023 | $703,675 | +23.3% | 11,113 | +5.5% | 0.00% | 0.0% |
Q1 2023 | $570,524 | -1.9% | 10,536 | -4.2% | 0.00% | 0.0% |
Q4 2022 | $581,855 | +11.9% | 10,995 | -1.6% | 0.00% | 0.0% |
Q3 2022 | $520,000 | -18.5% | 11,171 | 0.0% | 0.00% | -25.0% |
Q2 2022 | $638,000 | -12.6% | 11,171 | -6.4% | 0.00% | 0.0% |
Q1 2022 | $730,000 | +20.9% | 11,931 | +3.4% | 0.00% | +33.3% |
Q4 2021 | $604,000 | +84.1% | 11,535 | +30.9% | 0.00% | +50.0% |
Q3 2021 | $328,000 | -8.4% | 8,811 | +0.4% | 0.00% | 0.0% |
Q2 2021 | $358,000 | +7.8% | 8,773 | -10.3% | 0.00% | 0.0% |
Q1 2021 | $332,000 | +12.2% | 9,781 | +5.2% | 0.00% | 0.0% |
Q4 2020 | $296,000 | +52.6% | 9,296 | +23.0% | 0.00% | +100.0% |
Q3 2020 | $194,000 | +19.8% | 7,555 | +19.7% | 0.00% | 0.0% |
Q2 2020 | $162,000 | +125.0% | 6,310 | +33.9% | 0.00% | 0.0% |
Q1 2020 | $72,000 | -21.7% | 4,713 | +76.5% | 0.00% | 0.0% |
Q4 2019 | $92,000 | +360.0% | 2,671 | 0.0% | 0.00% | – |
Q3 2019 | $20,000 | -42.9% | 2,671 | 0.0% | 0.00% | – |
Q2 2019 | $35,000 | +6.1% | 2,671 | 0.0% | 0.00% | – |
Q1 2019 | $33,000 | +10.0% | 2,671 | 0.0% | 0.00% | – |
Q4 2018 | $30,000 | -48.3% | 2,671 | 0.0% | 0.00% | – |
Q3 2018 | $58,000 | +45.0% | 2,671 | +17.8% | 0.00% | – |
Q2 2018 | $40,000 | -16.7% | 2,267 | 0.0% | 0.00% | – |
Q1 2018 | $48,000 | +45.5% | 2,267 | 0.0% | 0.00% | – |
Q4 2017 | $33,000 | +120.0% | 2,267 | +142.2% | 0.00% | – |
Q3 2017 | $15,000 | +25.0% | 936 | 0.0% | 0.00% | – |
Q2 2017 | $12,000 | -20.0% | 936 | 0.0% | 0.00% | – |
Q1 2017 | $15,000 | +7.1% | 936 | 0.0% | 0.00% | – |
Q4 2016 | $14,000 | 0.0% | 936 | 0.0% | 0.00% | – |
Q3 2016 | $14,000 | -54.8% | 936 | +18.0% | 0.00% | – |
Q2 2016 | $31,000 | +40.9% | 793 | 0.0% | 0.00% | – |
Q1 2016 | $22,000 | -48.8% | 793 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $43,000 | +168.8% | 793 | +103.3% | 0.00% | – |
Q3 2015 | $16,000 | +33.3% | 390 | 0.0% | 0.00% | – |
Q2 2015 | $12,000 | – | 390 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 360,000 | $11,502,000 | 2.65% |
Redmile Group, LLC | 610,171 | $19,495,000 | 1.60% |
Pier Capital, LLC | 257,256 | $8,219,000 | 1.18% |
WALL STREET ASSOCIATES | 358,857 | $11,465,000 | 1.08% |
SENZAR ASSET MANAGEMENT, LLC | 161,300 | $5,154,000 | 0.88% |
Rhenman & Partners Asset Management AB | 206,000 | $6,582,000 | 0.79% |
EAM Investors, LLC | 152,389 | $4,869,000 | 0.57% |
EDMOND DE ROTHSCHILD (SUISSE) S.A. | 50,000 | $1,598,000 | 0.51% |
Visium Asset Management, LP | 1,051,479 | $33,595,000 | 0.48% |
SPHERA FUNDS MANAGEMENT LTD. | 128,000 | $4,090,000 | 0.40% |